StockCode
688506
Investors
中文 | EN

Certified as a “National Enterprise Technology Center” on February 25, 2022

时间:2022-02-25

On February 23, the five departments such as National Development and Reform Commission, Ministry of Science and Technology jointly issued the Notice of the Departments such as National Development and Reform Commission on Issuing the List of Newly Recognized and All National Enterprise Technology Centres in 2021 (Batch No. 28) " (FGGJ [2022] No. 158), and Biokin Pharmaceuticals and other 100 enterprises in China officially became newly recognized national enterprise technology centres.


Attachment 1

List of Newly Recognized (Batch No. 28) National Enterprise Technology Centres in 2021

S/N

Enterprise Name

Name of Enterprise Technology Centre

Region

76

Sichuan Biokin Pharmaceuticasl Co., Ltd.

Technology Center of Sichuan Biokin Pharmaceuticals Co., Ltd.

Sichuan Province

For recognition of national enterprise technology center, it is to make a comprehensive evaluation for enterprise innovation system and its operation and performance by the three dimensions of enterprise innovation input, innovation condition and innovation performance, which is a comprehensive recognition for the indicators such as enterprise innovation fund, innovation talents, technology accumulation, innovation platform, technology output and innovation benefits.

Under the leadership of Chairman Dr. Zhu Yi, Biokin Pharmaceuticals has always insisted on breakthrough innovation for breakthrough efficacy. Focusing on the field malignant tumors, the Company has successfully built up our world's leading multispecific R&D platforms of antibody drugs and ADC drugs, and have multiple FIC innovative drug projects in clinic trial phase. This time, Biokin Pharmaceutical was recognized as National Enterprise Technology Center, which was also a positive affirmation of the state on Biokins high-level innovation capability.

Biokin Pharmaceuticals will continue to make efforts to fully demonstrate the unique competitiveness of a Chinese pharmaceutical enterprise in the global innovation system.

虚线改像素.jpg

National Enterprise Technology Center is a system and mechanism of the state to give play to the main body role of an enterprise in technology innovation and establish and perfect the enterprise-led industrial technology R&D and innovation. According to the innovation-driven development requirements and economic restructuring needs, the National Development and Reform Commission takes the lead to make review and recognition for the enterprises with industry-leading technology innovation advantages and high-level technology innovation capability jointly with the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs and the State Administration of Taxation, with a purpose of giving recognition for the enterprise technology centres with strong innovation ability, good innovation mechanism and large leading and demonstration role, and giving policy supports to encourage and guide the industry backbone enterprises to drive industrial technology development and innovation ability improvement. 


Systimmune
Baili Pharmaceutical
Guorui Pharmaceutical
Baili-Bio
Jingxi Pharmaceutical
Hiatt Technology
Company Address:1#, Building 1,No.161, Baili Road, Cross-Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City
Postcode:610041
Tel:028-85183639
Sichuan Biokin Pharmaceuticals Co.,Ltd Copyright © 2018 All rights reserved
SICPB No. 17035664-1   
Internet Drug Information Service Qualification Certificate S/N: (C)-FJYX-2022-0343